首页> 美国卫生研究院文献>other >Relevance of autophagy to fatty liver diseases and potential therapeutic applications
【2h】

Relevance of autophagy to fatty liver diseases and potential therapeutic applications

机译:自噬与脂肪肝疾病的相关性和潜在的治疗应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Autophagy is an evolutionarily conserved lysosome-mediated cellular degradation program. Accumulating evidence shows that autophagy is important to the maintenance of liver homeostasis. Autophagy involves recycling of cellular nutrients recycling as well as quality control of subcellular organelles. Autophagy deficiency in the liver causes various liver pathologies. Fatty liver disease (FLD) is characterized by the accumulation of lipids in hepatocytes and the dysfunction in energy metabolism. Autophagy is negatively affected by the pathogenesis of FLD and the activation of autophagy could ameliorate steatosis, which suggests a potential therapeutic approach to FLD. In this review, we will discuss autophagy and its relevance to liver diseases, especially FLD. In addition we will discuss recent findings on potential therapeutic applications of autophagy modulators for FLD.
机译:自噬是一种进化保守的溶酶体介导的细胞降解程序。越来越多的证据表明,自噬对于维持肝脏的动态平衡很重要。自噬涉及细胞营养物质的再循环以及亚细胞器的质量控制。肝脏中自噬的缺乏会导致各种肝脏疾病。脂肪肝疾病(FLD)的特征在于肝细胞中脂质的积累和能量代谢功能障碍。自噬受FLD发病机制的负面影响,自噬的激活可减轻脂肪变性,这提示了FLD的潜在治疗方法。在这篇综述中,我们将讨论自噬及其与肝脏疾病特别是FLD的相关性。另外,我们将讨论关于FLD自噬调节剂潜在治疗应用的最新发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号